Navis Capital-backed Vietnamese drug producer OPV Pharmaceuticals JSC is said to be on the block with its shareholders targeting a 100% share sale, DealStreetAsia has learned.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
